RET and medullary thyroid gland carcinoma: In individuals with MTC, MEN2 or Hirschsprung disease, only RET gene testing is recommended (Rare and inherited disease eligibility criteria; https://www.england.nhs.uk/publication/national-genomic-test-directories/; version 7:2024; accessed 26/08/2024).